Related Experiment Video
Updated: May 1, 2026
08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
20.6K
[Prostate-rectum spacers: optimization of prostate cancer irradiation]
T Zilli1, E Benz2, R Miralbell1
1Service de radio-oncologie, hôpitaux universitaires de Genève, avenue Gabrielle-Perret-Gentil 4, 1205 Genève, Suisse.
Summary
Biodegradable spacers injected between the prostate and rectum create space, significantly reducing rectal radiation exposure. This novel technique shows promise for lowering toxicity in localized prostate cancer radiotherapy.
Area of Science:
- Radiation oncology
- Medical device technology
- Urology
Background:
- Dose escalation in prostate cancer radiotherapy improves outcomes but increases rectal toxicity.
- Optimizing radiotherapy requires minimizing radiation exposure to nearby organs at risk.
- Biodegradable spacers offer a novel approach to separate prostate and rectum.
Purpose of the Study:
- To systematically review the indications and benefits of prostate-rectum spacers.
- To evaluate dosimetric and clinical advantages of available spacer types.
- To summarize evidence on hydrogel, hyaluronic acid, collagen, and balloon spacers.
Main Methods:
- Systematic literature review of studies on prostate-rectum spacers.
- Analysis of dosimetric data regarding rectal dose reduction.
- Review of preliminary clinical outcomes and toxicity profiles.
Main Results:
- Spacers create 7-20 mm separation between prostate and rectum for 3-12 months.
- Significant reduction in rectal V70 (43%-84%) observed across spacer types.
- Preliminary data indicate good tolerance and potential reduction in acute side effects.
Conclusions:
- Prostate-rectum spacers are a promising new tool for reducing rectal toxicity in prostate cancer radiotherapy.
- Various spacer materials offer significant dosimetric benefits.
- Further clinical evaluation is warranted to confirm long-term efficacy and safety.
